Health Canada approves obesity drug Wegovy
About 42% of U.S. adults are obese, the CDC says. GLP-1 medications have changed the picture for people hoping to reduce ...
Most patients still need to be managed by oral medications to treat diabetes and not injections, at least in the early stages ...
Clinical trials show that around one in ten people are ‘non-responders’. Outside of trials, that figure might be much higher.
The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.
But their weight-loss properties grabbed the attention of the public and people without diabetes started seeking these ...
The Biden administration is proposing a major expansion of how Medicare and Medicaid cover the weight-loss drugs Wegovy and ...
The Biden administration plans to require Medicare and Medicaid to offer coverage of weight loss medications for patients ...
The Biden administration proposed expanding coverage of weight loss medication to Medicaid and Medicare recipients. RFK Jr.
There is some debate as to whether GLP-1 agonist drugs like Wegovy can lead to unhealthy muscle mass loss in addition to ...
The diabetes drug, Ozempic, has been in the headlines, causing quite a stir. Senior writer for Drugwatch.com, Terry Turner, ...
Pharmaceutical company Novo Nordisk has launched its mega-popular weight-loss drug Wegovy in China — but for a tiny fraction ...
Wegovy is a once-weekly injection approved by the U.S. Food and Drug Administration (FDA) to treat obesity in people 12 and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback